Pharmaceuticals

Impact Of Obesity On Personalized Medicine Growth Is Supporting Development Across The Personalized Medicine Market

May 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Value Of The Personalized Medicine Market Increase Between 2026 And 2030?

The personalized medicine market size has experienced rapid growth in recent years. It is anticipated to expand from $422.9 billion in 2025 to $469.11 billion in 2026, reflecting a compound annual growth rate (CAGR) of 10.9%. This historical growth can be attributed to factors such as the increasing prevalence of chronic diseases, advancements in genetic sequencing, higher healthcare expenditure, a growing awareness of personalized medicine, and the early adoption of digital health solutions.

The personalized medicine market size is poised for significant expansion in the coming years. It is projected to reach **$733.27 billion by 2030**, demonstrating a compound annual growth rate (CAGR) of **11.8%**. This anticipated growth over the forecast period is fueled by factors such as the integration of artificial intelligence in diagnostics and therapeutics, the broadening availability of gene and cell therapy products, the increasing demand for remote patient monitoring, the evolution of precision nutrition solutions, and the rising adoption of companion diagnostics. Prominent trends expected during this period include personalized genetic profiling, the development of targeted drugs, patient-centric care models, remote health monitoring, and lifestyle-based preventive therapies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10272&type=smp

What Core Drivers Are Transforming The Personalized Medicine Market?

The increasing number of people with obesity is anticipated to fuel the expansion of the personalized medicine market in the future. Obesity is defined as the unusual or excessive storage of fat, which has the potential to compromise an individual’s health. Personalized medicine is employed to target the specific genetic and molecular aspects that contribute to obesity, thereby delivering customized and effective solutions for individuals. For instance, in December 2024, the Office for Health Improvement and Disparities, a UK-based government department, reported that from 2022 to 2023, the percentage of women documented as living with obesity in early pregnancy was 25.4%, which experienced a slight increase to 26.2% from 2023 to 2024. As a result, the expanding obese population is propelling the growth of the personalized medicine market.

Which Segment Divisions Form The Structure Of The Personalized Medicine Market?

The personalized medicine market covered in this report is segmented –

1) By Product: Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness

2) By Application: Oncology, Neurology, Blood Transfusion Safety, Diabetes, Autoimmune Diseases, Cardiology, Other Applications

3) By End-use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Other End-Users

Subsegments:

1) By Personalized Medicine Diagnostics: Genetic Testing, Biomarker Testing, Companion Diagnostics, Molecular Imaging

2) By Personalized Medicine Therapeutics: Targeted Therapies, Gene Therapies, Monoclonal Antibodies, Cell and Gene Therapy Products

3) By Personalized Medical Care: Tailored Treatment Plans, Patient-Centric Care Models, Digital Health Solutions, Remote Patient Monitoring

4) By Personalized Nutrition And Wellness: Nutrigenomics, Customized Diet Plans, Supplement Personalization, Lifestyle Modification Programs

What Trends Are Influencing The Future Of The Personalized Medicine Market?

Leading companies active in the personalized medicine market are concentrating on developing advanced technologies, such as artificial intelligence (AI)-powered platforms, to improve diagnosis precision, customize treatments, and enhance the efficiency of clinical trials. These AI-driven platforms employ extensive data analysis to yield practical insights into disease advancement, patient reactions, and therapeutic results. For example, in April 2023, OM1, a US-based healthcare company that leverages real-world data and AI, obtained a patent for an AI-powered platform aimed at accelerating personalized medicine. This platform provides customized healthcare recommendations, supports healthcare providers in making informed decisions, and expedites clinical trials by effectively identifying suitable patient candidates. By integrating AI-driven analytics into healthcare operations, this technology furthers personalized medicine and strengthens market expansion.

Which Organizations Are Operating Within The Personalized Medicine Market?

Major companies operating in the personalized medicine market are Bayer AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, AstraZeneca plc, Abbott Laboratories, Danaher Corporation, Eli Lilly and Company, Decode Genetics Inc., GE HealthCare Technologies Inc., Roche Diagnostics, Genentech Inc., Biogen Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Myriad Genetics Inc., Verily Life Sciences LLC, Guardant Health Inc., Tempus Labs, Oxford Nanopore Technologies, Foundation Medicine Inc., NanoString Technologies Inc., Exagen Inc., Asuragen Inc., Personal Genome Diagnostics, Precision Biologics Inc., Strata Oncology, Genelex Corp, Invitae Corporation, Color Genomics, Helix OpCo LLC, 10x Genomics Inc., Agena Bioscience Inc., Natera Inc., Becton Dickinson and Company, PerkinElmer Inc., Sophia Genetics, Genomic Vision, Personalis Inc.

Access The Complete Personalized Medicine Market Report:

https://www.thebusinessresearchcompany.com/report/personalized-medicine-global-market-report

Which Region Stands As The Largest Contributor To The Personalized Medicine Market?

North America was the largest region in the personalized medicine market in 2025. Asia-pacific is expected to be the fastest-growing region in the global personalized medicine market during the forecast period. The regions covered in the personalized medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Personalized Medicine Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=10272&type=smp

Browse Through More Reports Similar to the Global Personalized Medicine Market 2026, By The Business Research Company

Personalized Medicine Market Report 2026

https://www.thebusinessresearchcompany.com/report/personalized-medicine-global-market-report

Genomics Personalized Health Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-personalized-health-global-market-report

Personalized Nutrition Market Report 2026

https://www.thebusinessresearchcompany.com/report/personalized-nutrition-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795